TADALAFIL

82612 reported adverse events

Drug classes: Phosphodiesterase 5 Inhibitor [EPC]

These side effects are most commonly reported by patients taking TADALAFIL:

# Side effect Count
0 DYSPNOEA 10270
1 HEADACHE 9226
2 DIARRHOEA 6505
3 NAUSEA 5545
4 DEATH 5013
5 DRUG INEFFECTIVE 4921
6 FATIGUE 4689
7 DIZZINESS 4319
8 PNEUMONIA 3714
9 COUGH 3367
See all common reactions for TADALAFIL

TADALAFIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATHETER SITE PRURITUS 222 0.2891
1 LIBIDO DISORDER 309 0.2749
2 CATHETER MANAGEMENT 230 0.2681
3 INFUSION SITE DISCHARGE 234 0.2647
4 CATHETER SITE DISCHARGE 204 0.2321
5 MALIGNANT MELANOMA IN SITU 265 0.2296
6 INFUSION SITE INFECTION 387 0.2294
7 CATHETER SITE ERYTHEMA 342 0.2020
8 PULMONARY ARTERIAL HYPERTENSION 2599 0.2017
9 PULMONARY ARTERIAL PRESSURE INCREASED 270 0.1871
See all enriched reactions for TADALAFIL